DAY 0 - Pre-Conference
Workshop: Early CMC Strategies for TIDES Modalities - Purity, Stability, & Manufacturability Learn how to assess purity, stability, and manufacturability risk for early TIDES candidates |
DAY 1
Opening Remarks: Europe's Next Leap in TIDES CEO Panel: Where is the Next $10B Opportunity in Oligos & Peptides? |
Refreshments & Networking Break |
Peptide & Oligonucleotide Engineering: The Next European Frontier Exploring modular design, conjugation chemistry, and half-life optimisation |
Lunch & Poster Exhibition |
Start-Up Pitches What Investors Want Lessons from Successful Oligo & Peptide Launches - Part 1 |
Refreshment & Networking Break |
Roundtable Discussions:
|
Cocktail Reception & The NextGen Biologics Awards |
End of Day 1 |
DAY 2
Lessons from Successful Oligo & Peptide Launches – Part 2 |
Coffee & Networking Break |
QbD: Oligo & Peptide Drug Substance & Product |
Lunch & Poster Exhibition |
Joint Session Across All Co-Located Events: AOCs & POCs |
Tea & Networking Break |
Joint Session Across All Co-Located Events: 2035 Outlook: Smart Factories & Predictive Controls How smart factories, digital process controls, and predictive analytics are transforming Antibody and Oligonucleotide
Conference Chair Wrap-Up |
End of Day 2 |
*Please note that this is a working agenda and is subject to change
